Search research articles
Contact Us
Filters
Showing results (81-90 of 759) with videos related to
Page
of 76
Sort By:
Progress in Cardiovascular Diseases
|
September 25, 2003
Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease
Scott M Grundy
The American Journal of Clinical Nutrition
|
June 24, 2004
Cholesterol gallstones: a fellow traveler with metabolic syndrome?
Scott M Grundy
The American Journal of Cardiology
|
August 27, 1984
Hyperlipoproteinemia: metabolic basis and rationale for therapy
S M Grundy
JAMA
|
July 17, 2012
Use of emerging lipoprotein risk factors in assessment of cardiovascular risk
Scott M Grundy
Circulation
|
December 8, 2004
Atherosclerosis imaging and the future of lipid management
Scott M Grundy
Postgraduate Medicine
|
November 21, 1998
Cholesterol management in high-risk patients without heart disease. When is lipid-lowering medication warranted for primary prevention?
S M Grundy
Endocrinology and Metabolism Clinics of North America
|
October 24, 1998
The role of cholesterol management in coronary disease risk reduction in elderly patients
S M Grundy
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 5, 2008
Metabolic syndrome pandemic
Scott M Grundy
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2008
Thyroid mimetic as an option for lowering low-density lipoprotein
Scott M Grundy
The American Journal of Managed Care
|
February 9, 2002
New cholesterol guidelines emphasize risk assessment
Scott M Grundy
Page
of 76
Search research articles
Search
Showing results (81-90 of 759) with videos related to
Sort By:
Page
of 76
Progress in Cardiovascular Diseases
|
September 25, 2003
Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease
Scott M Grundy
The American Journal of Clinical Nutrition
|
June 24, 2004
Cholesterol gallstones: a fellow traveler with metabolic syndrome?
Scott M Grundy
The American Journal of Cardiology
|
August 27, 1984
Hyperlipoproteinemia: metabolic basis and rationale for therapy
S M Grundy
JAMA
|
July 17, 2012
Use of emerging lipoprotein risk factors in assessment of cardiovascular risk
Scott M Grundy
Circulation
|
December 8, 2004
Atherosclerosis imaging and the future of lipid management
Scott M Grundy
Postgraduate Medicine
|
November 21, 1998
Cholesterol management in high-risk patients without heart disease. When is lipid-lowering medication warranted for primary prevention?
S M Grundy
Endocrinology and Metabolism Clinics of North America
|
October 24, 1998
The role of cholesterol management in coronary disease risk reduction in elderly patients
S M Grundy
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 5, 2008
Metabolic syndrome pandemic
Scott M Grundy
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2008
Thyroid mimetic as an option for lowering low-density lipoprotein
Scott M Grundy
The American Journal of Managed Care
|
February 9, 2002
New cholesterol guidelines emphasize risk assessment
Scott M Grundy
Page
of 76